Gregory Licholai

2008

In 2008, Gregory Licholai earned a total compensation of $504.7K as Vice President, Medical Affairs at Amicus Therapeutics, a 16% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$52,136
Option Awards$189,177
Salary$245,345
Other$17,996
Total$504,654

Licholai received $245.3K in salary, accounting for 49% of the total pay in 2008.

Licholai also received $52.1K in non-equity incentive plan, $189.2K in option awards and $18K in other compensation.

Rankings

In 2008, Gregory Licholai's compensation ranked 6,477th out of 9,135 executives tracked by ExecPay. In other words, Licholai earned more than 29.1% of executives.

ClassificationRankingPercentile
All
6,477
out of 9,135
29th
Division
Manufacturing
2,399
out of 3,436
30th
Major group
Chemicals And Allied Products
530
out of 815
35th
Industry group
Drugs
361
out of 597
40th
Industry
Pharmaceutical Preparations
266
out of 408
35th
Source: SEC filing on April 24, 2009.

Licholai's colleagues

We found four more compensation records of executives who worked with Gregory Licholai at Amicus Therapeutics in 2008.

2008

John Crowley

Amicus Therapeutics

Chairman

2008

David Lockhart

Amicus Therapeutics

Chief Scientific Officer

2008

James Dentzer

Amicus Therapeutics

Chief Financial Officer

2008

Matthew Patterson

Amicus Therapeutics

Chief Executive Officer

You may also like